Barack Obama, in his state-of-the-union speech on February
12th, called fora new era of scientific discovery. "Now is the time to reach a
level of research and development not seen since the height of the space race,"
he declared. He praised projects to map the human brain and accelerate
regenerative medicine. This would mean spending more on research. As The
Economist went to press, America’s government was about to do the
opposite. Federal spending is due to be cut on March 1st, the
result of a long brawl over the deficit. Complex politics triggered this
"sequester" (Congress excels at nothing if not elaborate dysfunction) but the
sequester itself is brutally simple. America will cut $85 billion from this
year’s budget (about 2.5% of spending), split between military and non-military
programmes. Among the areas to be squeezed is R&D, and medical research in
particular. For year America has enjoyed pre-eminence in
research, but this is fading. Chinese investment (including both public and
private money) more than quintupled from 2000 to 2010, to $160 billion, in 2005
prices. America’s R&D spending rose by just 22% over that period, according
to the OECD. Research also make up a smaller portion of America’s economy than
some other countries’. In a ranking of R&D spending as a share of GDP,
America came tenth in 2011. A decade earlier it was sixth.
Nevertheless, America remains the world’s biggest engine for innovation. It
spent $366 billion on research in 2011, compared with $275 billion by all 27
countries of the European Union. Despite China’s rapid ascent, America still
spends more than twice as much on R&D. Subsidies help. America’s government
pays for about one-third of all domestic research and for most basic
science. Medicine is one of the main beneficiaries. America’s
National Institutes of Health(NIH) is the world’s biggest funder of biomedical
research. It pays for risky basic science; companies pay for later stages of
development. For example, the NIH supported early research into monoclonal
antibodies. By 2010 such research underpinned five of America’s 20 bestselling
drugs. As drug firms trim their budget, the NIH’s work is becoming even more
vital. But since 2003, inflation-adjusted spending on medical research has
declined. We can infer from the first paragraph that ______.
A.U.S. will spend more on research
B.Obama objected to the project to map the human brain
C.Obama praised scientists’ endeavour on scientific research
D.regenerative medicine is an area America focuses on for long